Neurochemical enhancement of conscious error awareness.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Robert HesterMark A Bellgrove

Abstract

How the brain monitors ongoing behavior for performance errors is a central question of cognitive neuroscience. Diminished awareness of performance errors limits the extent to which humans engage in corrective behavior and has been linked to loss of insight in a number of psychiatric syndromes (e.g., attention deficit hyperactivity disorder, drug addiction). These conditions share alterations in monoamine signaling that may influence the neural mechanisms underlying error processing, but our understanding of the neurochemical drivers of these processes is limited. We conducted a randomized, double-blind, placebo-controlled, cross-over design of the influence of methylphenidate, atomoxetine, and citalopram on error awareness in 27 healthy participants. The error awareness task, a go/no-go response inhibition paradigm, was administered to assess the influence of monoaminergic agents on performance errors during fMRI data acquisition. A single dose of methylphenidate, but not atomoxetine or citalopram, significantly improved the ability of healthy volunteers to consciously detect performance errors. Furthermore, this behavioral effect was associated with a strengthening of activation differences in the dorsal anterior cingulate co...Continue Reading

Citations

Nov 21, 2012·Journal of Cognitive Neuroscience·L Sanjay NandamMark A Bellgrove
Jul 26, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ana Navarro-CebrianAndrew S Kayser
Aug 2, 2013·CNS Spectrums·Maartje LuijtenIngmar H A Franken
May 15, 2013·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Madeleine J GroomChris P Hollis
Mar 17, 2016·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Philippa HüpenOliver Tucha
Mar 25, 2014·Biological Psychiatry·Zheng YeJames B Rowe
Jan 16, 2014·The International Journal of Neuropsychopharmacology·A M W LinssenW J Riedel
Jun 14, 2013·The International Journal of Neuropsychopharmacology·Sabrina SchneiderAnn-Christine Ehlis
Sep 21, 2013·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·David BorsookLino Becerra
Mar 23, 2013·Journal of Psychopharmacology·Samuel R Chamberlain, Trevor W Robbins
Feb 22, 2017·Consciousness and Cognition·Lisa M FitzgeraldPaul M Dockree
Jan 3, 2014·Physiological Reviews·Markus UllspergerGerhard Jocham
Apr 15, 2016·Harvard Review of Psychiatry·Paola LandiLiliana Dell'Osso
Oct 8, 2020·Cognitive, Affective & Behavioral Neuroscience·Hans KirschnerMarkus Ullsperger
Mar 4, 2021·Neuroscience and Biobehavioral Reviews·Shivam KalhanMarta I Garrido
Sep 20, 2020·Neurobiology of Aging·Joyce SimRobert Hester
Nov 5, 2019·Pediatric Clinics of North America·Timothy E Wilens, Tamar Arit Kaminski
Jul 6, 2021·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jessica S FlanneryMatthew T Sutherland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.